Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 23, 16:00
2133.85
13.35 (0.63%)
VOLUME 12,914
LIVE
NSE
Apr 23, 15:57
2135.55
13.65 (0.64%)
VOLUME 545,145
News on Dr Reddys Laboratories
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr. Reddy’s Lab Q4 PAT may dip 17.7% YoY to Rs. 269.4 cr: KR Choksey

3.17 pm | 23 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 11.1 percent Y-o-Y (down 3.7 percent Q-o-Q) to Rs. 3,663.7 crore, according to KR Choksey....

Dr. Reddy’s Labs Q4 PAT may dip 4.8% YoY to Rs. 300 cr: HDFC Securities

12.57 pm | 20 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 1 percent Y-o-Y (down 5.7 percent Q-o-Q) to Rs. 3,590 crore, according to HDFC Securities....

Dr Reddy's Q4 PAT may dip 16.7% YoY to Rs. 268.4 cr: Edelweiss

6.03 pm | 16 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 3.7 percent Y-o-Y (down 10.1 percent Q-o-Q) to Rs. 3,421.2 crore, according to Edelweiss....

Dr Reddy's gets EIR from USFDA for Cuernavaca plant in Mexico

5.52 pm | 10 Apr 2018 |  Source: PTI

The company had earlier said in a regulatory filing that audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico by the United ...

News highlights of the day: Dow Jones drops 500 points on Trump's tweet on Amazon, rising trade war fears

3.20 pm | 02 Apr 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Dr Reddy's, Promius Pharma file NDA for migraine candidate

1.45 pm | 02 Apr 2018 |  Source: PTI

Senior Vice President, Proprietary Products and President, Promius Pharma, Anil Namboodiripad said the NDA for DFN-02 is an important step forward in ...

Dr Reddy's ropes in ex-Teva executive to run operations

5.04 pm | 29 Mar 2018 |  Source: Moneycontrol.com

Israeli is expected to steer the company out of its current slump, which is struggling with regulatory compliance issues at its plants and plummeting ...

News highlights: CEA says report on direct tax reforms to release in 4-5 months

3.05 pm | 26 Mar 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Dr Reddy's launches generic nausea drug in US

2.20 pm | 26 Mar 2018 |  Source: PTI

The Hyderabad-based firm launched the product after getting approval from the US Food and Drug Administration (USFDA), Dr Reddy's Labs said in a s...

News highlights of the day: Centre, states sanction Rs 10,000 cr refunds due to exporters, says FinMin

8.30 pm | 16 Mar 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Dr Reddy's gets 4 observations from USFDA for Telangana plant

3.34 pm | 16 Mar 2018 |  Source: PTI

"The audit of our API Hyderabad plant 1 at Jinnaram Mandal, Medak district, Telangana, by the USFDA has been completed today. We have been issued a Fo...

Dr Reddy’s Laboratories declines 3% on Form 483 from USFDA

3.33 pm | 16 Mar 2018 |  Source: Moneycontrol.com

The audit of company’s Telengana units has been completed today by the USFDA with four observations which will be addressed comprehensively within s...

USFDA issues Form 483 to Dr Reddy's Telengana unit

3.19 pm | 16 Mar 2018 |  Source: Moneycontrol.com

The audit of Dr Reddy’s Laboratories’ API Hyderabad Plant 1 at Jinnaram Mandal, Medak Telengana by the USFDA has been completed today. The company...

Dr Reddy's launches allergy relief tablets in US

12.26 pm | 16 Mar 2018 |  Source: PTI

In a BSE filing, Dr Reddy's Laboratories said it had "launched levocetirizine dihydrochloride tablets USP, 5 mg, an over-the-counter therapeutic e...

Dr Reddys Laboratories launches Levocetirizine Dihydrochloride tablets in US

11.59 am | 16 Mar 2018 |  Source: Moneycontrol.com

Dr Reddy’s Laboratories launched Levocetirizine Dihydrochloride tablets USP, 5 mg, an over the counter therapeutic equivalent generic version of Xyz...

Buy Dr Reddy's Laboratories; target of Rs 3450: Dolat Capital

5.37 pm | 29 Jan 2018 |  Source: Moneycontrol.com

Dolat Capital is bullish on Dr Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 3450 in its research report ...

Hope to resolve Srikakulam with US FDA soon, says DRL 

8.37 am | 29 Jan 2018 |  Source: CNBC-TV18

From the pharmaceutical space, Dr Reddys Laboratories (DRL) reported a mixed set of earnings this quarter. In an interview to CNBC-TV18, Saumen Chakra...

Hope to resolve Srikakulam with US FDA soon, says Dr Reddy's

8.37 am | 29 Jan 2018 |  Source: CNBC-TV18

From the pharmaceutical space, Dr Reddys Laboratories (DRL) reported a mixed set of earnings this quarter. In an interview to CNBC-TV18, Saumen Chakra...

Dr Reddy's Labs Q3 profit tanks 29% to Rs 334.4 cr but North America biz improves QoQ 

12.15 pm | 25 Jan 2018 |  Source: Moneycontrol.com

Sequential decline in bottomline was just 0.88 percent due to improvement in North America business....

1 2
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.